174 related articles for article (PubMed ID: 12790579)
1. Solid-phase synthesis of HTLV-1 protease inhibitors containing hydroxyethylamine dipeptide isostere.
Akaji K; Teruya K; Aimoto S
J Org Chem; 2003 Jun; 68(12):4755-63. PubMed ID: 12790579
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of phosphino dipeptide isostere inhibitor of human beta-secretase (BACE1).
Manzenrieder F; Frank AO; Huber T; Dorner-Ciossek C; Kessler H
Bioorg Med Chem; 2007 Jun; 15(12):4136-43. PubMed ID: 17433698
[TBL] [Abstract][Full Text] [Related]
3. Small dipeptide-based HIV protease inhibitors containing the hydroxymethylcarbonyl isostere as an ideal transition-state mimic.
Kiso Y; Matsumoto H; Mizumoto S; Kimura T; Fujiwara Y; Akaji K
Biopolymers; 1999; 51(1):59-68. PubMed ID: 10380353
[TBL] [Abstract][Full Text] [Related]
4. Reduction of peptide character of HIV protease inhibitors that exhibit nanomolar potency against multidrug resistant HIV-1 strains.
Tamamura H; Koh Y; Ueda S; Sasaki Y; Yamasaki T; Aoki M; Maeda K; Watai Y; Arikuni H; Otaka A; Mitsuya H; Fujii N
J Med Chem; 2003 Apr; 46(9):1764-8. PubMed ID: 12699395
[TBL] [Abstract][Full Text] [Related]
5. An efficient, stereoselective synthesis of the hydroxyethylene dipeptide isostere core for the HIV protease inhibitor A-792611.
Engstrom K; Henry R; Hollis LS; Kotecki B; Marsden I; Pu YM; Wagaw S; Wang W
J Org Chem; 2006 Jul; 71(14):5369-72. PubMed ID: 16808529
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of retro-inverso modifications of HTLV-1 protease inhibitors containing a hydroxyethylamine isoster.
Tatsumi T; Awahara C; Naka H; Aimoto S; Konno H; Nosaka K; Akaji K
Bioorg Med Chem; 2010 Apr; 18(7):2720-7. PubMed ID: 20226680
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of a new hydroxyethylene dipeptide isostere Phe psi [CH2CH (OH)]Phe as HIV-1 protease inhibitor.
Chen HG; Sawyer TK; Wuts PG
Zhongguo Yao Li Xue Bao; 1994 Jan; 15(1):33-5. PubMed ID: 8010081
[TBL] [Abstract][Full Text] [Related]
8. Structure-based design: synthesis and biological evaluation of a series of novel cycloamide-derived HIV-1 protease inhibitors.
Ghosh AK; Swanson LM; Cho H; Leshchenko S; Hussain KA; Kay S; Walters DE; Koh Y; Mitsuya H
J Med Chem; 2005 May; 48(10):3576-85. PubMed ID: 15887965
[TBL] [Abstract][Full Text] [Related]
9. Solid-phase synthesis of bicyclic dipeptide mimetics by intramolecular cyclization of alcohols, thiols, amines, and amides with N-acyliminium intermediates.
Nielsen TE; Le Quement S; Meldal M
Org Lett; 2005 Aug; 7(17):3601-4. PubMed ID: 16092829
[TBL] [Abstract][Full Text] [Related]
10. Indium-mediated atom-transfer and reductive radical cyclizations of iodoalkynes: synthesis and biological evaluation of HIV-protease inhibitors.
Yanada R; Koh Y; Nishimori N; Matsumura A; Obika S; Mitsuya H; Fujii N; Takemoto Y
J Org Chem; 2004 Apr; 69(7):2417-22. PubMed ID: 15049639
[TBL] [Abstract][Full Text] [Related]
11. Solid-phase syntheses of olefin-containing inhibitors for HTLV-1 protease using the Horner-Emmons reaction.
Bang JK; Naka H; Teruya K; Aimoto S; Konno H; Nosaka K; Tatsumi T; Akaji K
J Org Chem; 2005 Dec; 70(25):10596-9. PubMed ID: 16323881
[TBL] [Abstract][Full Text] [Related]
12. Identification of peptidomimetic HTLV-I protease inhibitors containing hydroxymethylcarbonyl (HMC) isostere as the transition-state mimic.
Maegawa H; Kimura T; Arii Y; Matsui Y; Kasai S; Hayashi Y; Kiso Y
Bioorg Med Chem Lett; 2004 Dec; 14(23):5925-9. PubMed ID: 15501070
[TBL] [Abstract][Full Text] [Related]
13. Stereocontrolled synthesis and biological activity of two diastereoisomers of the potent HIV-1 protease inhibitor saquinavir.
Righi G; Ciambrone S; Bonini C; Campaner P
Bioorg Med Chem; 2008 Jan; 16(2):902-8. PubMed ID: 17964171
[TBL] [Abstract][Full Text] [Related]
14. Evaluations of substrate specificity and inhibition at PR/p3 cleavage site of HTLV-1 protease.
Naka H; Teruya K; Bang JK; Aimoto S; Tatsumi T; Konno H; Nosaka K; Akaji K
Bioorg Med Chem Lett; 2006 Jul; 16(14):3761-4. PubMed ID: 16682197
[TBL] [Abstract][Full Text] [Related]
15. Structure-activity relationship of small-sized HIV protease inhibitors containing allophenylnorstatine.
Mimoto T; Kato R; Takaku H; Nojima S; Terashima K; Misawa S; Fukazawa T; Ueno T; Sato H; Shintani M; Kiso Y; Hayashi H
J Med Chem; 1999 May; 42(10):1789-802. PubMed ID: 10346931
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of a Gln-Phe hydroxy-ethylene dipeptide isostere.
Haug BE; Rich DH
Org Lett; 2004 Dec; 6(25):4783-6. PubMed ID: 15575685
[TBL] [Abstract][Full Text] [Related]
17. Novel HIV-protease inhibitors containing beta-hydroxyether and -thioether dipeptide isostere surrogates: modification of the P3 ligand.
Patel NM; Bennett F; Girijavallabhan VM; Dasmahapatra B; Butkiewicz N; Hart A
Bioorg Med Chem Lett; 1998 Apr; 8(8):931-4. PubMed ID: 9871514
[TBL] [Abstract][Full Text] [Related]
18. Design and synthesis of potent inhibitors of the malaria aspartyl proteases plasmepsin I and II. Use of solid-phase synthesis to explore novel statine motifs.
Johansson PO; Chen Y; Belfrage AK; Blackman MJ; Kvarnström I; Jansson K; Vrang L; Hamelink E; Hallberg A; Rosenquist A; Samuelsson B
J Med Chem; 2004 Jun; 47(13):3353-66. PubMed ID: 15189032
[TBL] [Abstract][Full Text] [Related]
19. Aminoethylenes: a tetrahedral intermediate isostere yielding potent inhibitors of the aspartyl protease BACE-1.
Yang W; Lu W; Lu Y; Zhong M; Sun J; Thomas AE; Wilkinson JM; Fucini RV; Lam M; Randal M; Shi XP; Jacobs JW; McDowell RS; Gordon EM; Ballinger MD
J Med Chem; 2006 Feb; 49(3):839-42. PubMed ID: 16451048
[TBL] [Abstract][Full Text] [Related]
20. Countering cooperative effects in protease inhibitors using constrained beta-strand-mimicking templates in focused combinatorial libraries.
Reid RC; Pattenden LK; Tyndall JD; Martin JL; Walsh T; Fairlie DP
J Med Chem; 2004 Mar; 47(7):1641-51. PubMed ID: 15027855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
